COVID-19 Impact on Global Dolutegravir Market Insights, Forecast to 2026
Dolutegravir market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dolutegravir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dolutegravir market is segmented into
The Dolutegravir market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dolutegravir market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dolutegravir Market Share Analysis
Dolutegravir market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dolutegravir business, the date to enter into the Dolutegravir market, Dolutegravir product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Dolutegravir market is segmented into
- 10mg Tablets
- 50mg Tablets
- Prevent HIV Infection Following Potential Exposure
- Other
The Dolutegravir market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dolutegravir market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dolutegravir Market Share Analysis
Dolutegravir market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dolutegravir business, the date to enter into the Dolutegravir market, Dolutegravir product introduction, recent developments, etc.
The major vendors covered:
- ViiV Healthcare (GSK)
- Shanghai Desano Pharmaceuticals
- Mylan
- Aurobindo Pharma
- LAURUS Labs
- Adcock Ingram Limited
1 STUDY COVERAGE
1.1 Dolutegravir Product Introduction
1.2 Market Segments
1.3 Key Dolutegravir Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dolutegravir Market Size Growth Rate by Type
1.4.2 10mg Tablets
1.4.3 50mg Tablets
1.5 Market by Application
1.5.1 Global Dolutegravir Market Size Growth Rate by Application
1.5.2 Prevent HIV Infection Following Potential Exposure
1.5.3 Other
1.6 Coronavirus Disease 2019 (Covid-19): Dolutegravir Industry Impact
1.6.1 How the Covid-19 is Affecting the Dolutegravir Industry
1.6.1.1 Dolutegravir Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Dolutegravir Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Dolutegravir Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Dolutegravir Market Size Estimates and Forecasts
2.1.1 Global Dolutegravir Revenue 2015-2026
2.1.2 Global Dolutegravir Sales 2015-2026
2.2 Dolutegravir Market Size by Region: 2020 Versus 2026
2.2.1 Global Dolutegravir Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dolutegravir Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DOLUTEGRAVIR COMPETITOR LANDSCAPE BY PLAYERS
3.1 Dolutegravir Sales by Manufacturers
3.1.1 Dolutegravir Sales by Manufacturers (2015-2020)
3.1.2 Dolutegravir Sales Market Share by Manufacturers (2015-2020)
3.2 Dolutegravir Revenue by Manufacturers
3.2.1 Dolutegravir Revenue by Manufacturers (2015-2020)
3.2.2 Dolutegravir Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dolutegravir Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dolutegravir Revenue in 2019
3.2.5 Global Dolutegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dolutegravir Price by Manufacturers
3.4 Dolutegravir Manufacturing Base Distribution, Product Types
3.4.1 Dolutegravir Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dolutegravir Product Type
3.4.3 Date of International Manufacturers Enter into Dolutegravir Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Dolutegravir Market Size by Type (2015-2020)
4.1.1 Global Dolutegravir Sales by Type (2015-2020)
4.1.2 Global Dolutegravir Revenue by Type (2015-2020)
4.1.3 Dolutegravir Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dolutegravir Market Size Forecast by Type (2021-2026)
4.2.1 Global Dolutegravir Sales Forecast by Type (2021-2026)
4.2.2 Global Dolutegravir Revenue Forecast by Type (2021-2026)
4.2.3 Dolutegravir Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dolutegravir Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Dolutegravir Market Size by Application (2015-2020)
5.1.1 Global Dolutegravir Sales by Application (2015-2020)
5.1.2 Global Dolutegravir Revenue by Application (2015-2020)
5.1.3 Dolutegravir Price by Application (2015-2020)
5.2 Dolutegravir Market Size Forecast by Application (2021-2026)
5.2.1 Global Dolutegravir Sales Forecast by Application (2021-2026)
5.2.2 Global Dolutegravir Revenue Forecast by Application (2021-2026)
5.2.3 Global Dolutegravir Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Dolutegravir by Country
6.1.1 North America Dolutegravir Sales by Country
6.1.2 North America Dolutegravir Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dolutegravir Market Facts & Figures by Type
6.3 North America Dolutegravir Market Facts & Figures by Application
7 EUROPE
7.1 Europe Dolutegravir by Country
7.1.1 Europe Dolutegravir Sales by Country
7.1.2 Europe Dolutegravir Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dolutegravir Market Facts & Figures by Type
7.3 Europe Dolutegravir Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Dolutegravir by Region
8.1.1 Asia Pacific Dolutegravir Sales by Region
8.1.2 Asia Pacific Dolutegravir Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dolutegravir Market Facts & Figures by Type
8.3 Asia Pacific Dolutegravir Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Dolutegravir by Country
9.1.1 Latin America Dolutegravir Sales by Country
9.1.2 Latin America Dolutegravir Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dolutegravir Market Facts & Figures by Type
9.3 Central & South America Dolutegravir Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Dolutegravir by Country
10.1.1 Middle East and Africa Dolutegravir Sales by Country
10.1.2 Middle East and Africa Dolutegravir Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dolutegravir Market Facts & Figures by Type
10.3 Middle East and Africa Dolutegravir Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 ViiV Healthcare (GSK)
11.1.1 ViiV Healthcare (GSK) Corporation Information
11.1.2 ViiV Healthcare (GSK) Description, Business Overview and Total Revenue
11.1.3 ViiV Healthcare (GSK) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ViiV Healthcare (GSK) Dolutegravir Products Offered
11.1.5 ViiV Healthcare (GSK) Recent Development
11.2 Shanghai Desano Pharmaceuticals
11.2.1 Shanghai Desano Pharmaceuticals Corporation Information
11.2.2 Shanghai Desano Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Shanghai Desano Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shanghai Desano Pharmaceuticals Dolutegravir Products Offered
11.2.5 Shanghai Desano Pharmaceuticals Recent Development
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Description, Business Overview and Total Revenue
11.3.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mylan Dolutegravir Products Offered
11.3.5 Mylan Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Corporation Information
11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Pharma Dolutegravir Products Offered
11.4.5 Aurobindo Pharma Recent Development
11.5 LAURUS Labs
11.5.1 LAURUS Labs Corporation Information
11.5.2 LAURUS Labs Description, Business Overview and Total Revenue
11.5.3 LAURUS Labs Sales, Revenue and Gross Margin (2015-2020)
11.5.4 LAURUS Labs Dolutegravir Products Offered
11.5.5 LAURUS Labs Recent Development
11.6 Adcock Ingram Limited
11.6.1 Adcock Ingram Limited Corporation Information
11.6.2 Adcock Ingram Limited Description, Business Overview and Total Revenue
11.6.3 Adcock Ingram Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Adcock Ingram Limited Dolutegravir Products Offered
11.6.5 Adcock Ingram Limited Recent Development
11.1 ViiV Healthcare (GSK)
11.1.1 ViiV Healthcare (GSK) Corporation Information
11.1.2 ViiV Healthcare (GSK) Description, Business Overview and Total Revenue
11.1.3 ViiV Healthcare (GSK) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ViiV Healthcare (GSK) Dolutegravir Products Offered
11.1.5 ViiV Healthcare (GSK) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Dolutegravir Market Estimates and Projections by Region
12.1.1 Global Dolutegravir Sales Forecast by Regions 2021-2026
12.1.2 Global Dolutegravir Revenue Forecast by Regions 2021-2026
12.2 North America Dolutegravir Market Size Forecast (2021-2026)
12.2.1 North America: Dolutegravir Sales Forecast (2021-2026)
12.2.2 North America: Dolutegravir Revenue Forecast (2021-2026)
12.2.3 North America: Dolutegravir Market Size Forecast by Country (2021-2026)
12.3 Europe Dolutegravir Market Size Forecast (2021-2026)
12.3.1 Europe: Dolutegravir Sales Forecast (2021-2026)
12.3.2 Europe: Dolutegravir Revenue Forecast (2021-2026)
12.3.3 Europe: Dolutegravir Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dolutegravir Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dolutegravir Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dolutegravir Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dolutegravir Market Size Forecast by Region (2021-2026)
12.5 Latin America Dolutegravir Market Size Forecast (2021-2026)
12.5.1 Latin America: Dolutegravir Sales Forecast (2021-2026)
12.5.2 Latin America: Dolutegravir Revenue Forecast (2021-2026)
12.5.3 Latin America: Dolutegravir Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dolutegravir Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dolutegravir Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dolutegravir Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dolutegravir Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dolutegravir Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Dolutegravir Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Dolutegravir Product Introduction
1.2 Market Segments
1.3 Key Dolutegravir Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dolutegravir Market Size Growth Rate by Type
1.4.2 10mg Tablets
1.4.3 50mg Tablets
1.5 Market by Application
1.5.1 Global Dolutegravir Market Size Growth Rate by Application
1.5.2 Prevent HIV Infection Following Potential Exposure
1.5.3 Other
1.6 Coronavirus Disease 2019 (Covid-19): Dolutegravir Industry Impact
1.6.1 How the Covid-19 is Affecting the Dolutegravir Industry
1.6.1.1 Dolutegravir Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Dolutegravir Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Dolutegravir Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Dolutegravir Market Size Estimates and Forecasts
2.1.1 Global Dolutegravir Revenue 2015-2026
2.1.2 Global Dolutegravir Sales 2015-2026
2.2 Dolutegravir Market Size by Region: 2020 Versus 2026
2.2.1 Global Dolutegravir Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dolutegravir Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL DOLUTEGRAVIR COMPETITOR LANDSCAPE BY PLAYERS
3.1 Dolutegravir Sales by Manufacturers
3.1.1 Dolutegravir Sales by Manufacturers (2015-2020)
3.1.2 Dolutegravir Sales Market Share by Manufacturers (2015-2020)
3.2 Dolutegravir Revenue by Manufacturers
3.2.1 Dolutegravir Revenue by Manufacturers (2015-2020)
3.2.2 Dolutegravir Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dolutegravir Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dolutegravir Revenue in 2019
3.2.5 Global Dolutegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dolutegravir Price by Manufacturers
3.4 Dolutegravir Manufacturing Base Distribution, Product Types
3.4.1 Dolutegravir Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dolutegravir Product Type
3.4.3 Date of International Manufacturers Enter into Dolutegravir Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Dolutegravir Market Size by Type (2015-2020)
4.1.1 Global Dolutegravir Sales by Type (2015-2020)
4.1.2 Global Dolutegravir Revenue by Type (2015-2020)
4.1.3 Dolutegravir Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dolutegravir Market Size Forecast by Type (2021-2026)
4.2.1 Global Dolutegravir Sales Forecast by Type (2021-2026)
4.2.2 Global Dolutegravir Revenue Forecast by Type (2021-2026)
4.2.3 Dolutegravir Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dolutegravir Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Dolutegravir Market Size by Application (2015-2020)
5.1.1 Global Dolutegravir Sales by Application (2015-2020)
5.1.2 Global Dolutegravir Revenue by Application (2015-2020)
5.1.3 Dolutegravir Price by Application (2015-2020)
5.2 Dolutegravir Market Size Forecast by Application (2021-2026)
5.2.1 Global Dolutegravir Sales Forecast by Application (2021-2026)
5.2.2 Global Dolutegravir Revenue Forecast by Application (2021-2026)
5.2.3 Global Dolutegravir Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Dolutegravir by Country
6.1.1 North America Dolutegravir Sales by Country
6.1.2 North America Dolutegravir Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dolutegravir Market Facts & Figures by Type
6.3 North America Dolutegravir Market Facts & Figures by Application
7 EUROPE
7.1 Europe Dolutegravir by Country
7.1.1 Europe Dolutegravir Sales by Country
7.1.2 Europe Dolutegravir Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dolutegravir Market Facts & Figures by Type
7.3 Europe Dolutegravir Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Dolutegravir by Region
8.1.1 Asia Pacific Dolutegravir Sales by Region
8.1.2 Asia Pacific Dolutegravir Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dolutegravir Market Facts & Figures by Type
8.3 Asia Pacific Dolutegravir Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Dolutegravir by Country
9.1.1 Latin America Dolutegravir Sales by Country
9.1.2 Latin America Dolutegravir Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dolutegravir Market Facts & Figures by Type
9.3 Central & South America Dolutegravir Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Dolutegravir by Country
10.1.1 Middle East and Africa Dolutegravir Sales by Country
10.1.2 Middle East and Africa Dolutegravir Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dolutegravir Market Facts & Figures by Type
10.3 Middle East and Africa Dolutegravir Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 ViiV Healthcare (GSK)
11.1.1 ViiV Healthcare (GSK) Corporation Information
11.1.2 ViiV Healthcare (GSK) Description, Business Overview and Total Revenue
11.1.3 ViiV Healthcare (GSK) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ViiV Healthcare (GSK) Dolutegravir Products Offered
11.1.5 ViiV Healthcare (GSK) Recent Development
11.2 Shanghai Desano Pharmaceuticals
11.2.1 Shanghai Desano Pharmaceuticals Corporation Information
11.2.2 Shanghai Desano Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Shanghai Desano Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shanghai Desano Pharmaceuticals Dolutegravir Products Offered
11.2.5 Shanghai Desano Pharmaceuticals Recent Development
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Description, Business Overview and Total Revenue
11.3.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Mylan Dolutegravir Products Offered
11.3.5 Mylan Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Corporation Information
11.4.2 Aurobindo Pharma Description, Business Overview and Total Revenue
11.4.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Aurobindo Pharma Dolutegravir Products Offered
11.4.5 Aurobindo Pharma Recent Development
11.5 LAURUS Labs
11.5.1 LAURUS Labs Corporation Information
11.5.2 LAURUS Labs Description, Business Overview and Total Revenue
11.5.3 LAURUS Labs Sales, Revenue and Gross Margin (2015-2020)
11.5.4 LAURUS Labs Dolutegravir Products Offered
11.5.5 LAURUS Labs Recent Development
11.6 Adcock Ingram Limited
11.6.1 Adcock Ingram Limited Corporation Information
11.6.2 Adcock Ingram Limited Description, Business Overview and Total Revenue
11.6.3 Adcock Ingram Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Adcock Ingram Limited Dolutegravir Products Offered
11.6.5 Adcock Ingram Limited Recent Development
11.1 ViiV Healthcare (GSK)
11.1.1 ViiV Healthcare (GSK) Corporation Information
11.1.2 ViiV Healthcare (GSK) Description, Business Overview and Total Revenue
11.1.3 ViiV Healthcare (GSK) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ViiV Healthcare (GSK) Dolutegravir Products Offered
11.1.5 ViiV Healthcare (GSK) Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Dolutegravir Market Estimates and Projections by Region
12.1.1 Global Dolutegravir Sales Forecast by Regions 2021-2026
12.1.2 Global Dolutegravir Revenue Forecast by Regions 2021-2026
12.2 North America Dolutegravir Market Size Forecast (2021-2026)
12.2.1 North America: Dolutegravir Sales Forecast (2021-2026)
12.2.2 North America: Dolutegravir Revenue Forecast (2021-2026)
12.2.3 North America: Dolutegravir Market Size Forecast by Country (2021-2026)
12.3 Europe Dolutegravir Market Size Forecast (2021-2026)
12.3.1 Europe: Dolutegravir Sales Forecast (2021-2026)
12.3.2 Europe: Dolutegravir Revenue Forecast (2021-2026)
12.3.3 Europe: Dolutegravir Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dolutegravir Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dolutegravir Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dolutegravir Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dolutegravir Market Size Forecast by Region (2021-2026)
12.5 Latin America Dolutegravir Market Size Forecast (2021-2026)
12.5.1 Latin America: Dolutegravir Sales Forecast (2021-2026)
12.5.2 Latin America: Dolutegravir Revenue Forecast (2021-2026)
12.5.3 Latin America: Dolutegravir Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dolutegravir Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dolutegravir Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dolutegravir Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dolutegravir Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dolutegravir Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Dolutegravir Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Dolutegravir Market Segments
Table 2. Ranking of Global Top Dolutegravir Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dolutegravir Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 10mg Tablets
Table 5. Major Manufacturers of 50mg Tablets
Table 6. COVID-19 Impact Global Market: (Four Dolutegravir Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Dolutegravir Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Dolutegravir Players to Combat Covid-19 Impact
Table 11. Global Dolutegravir Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Dolutegravir Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Dolutegravir Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Dolutegravir Sales Market Share by Regions (2015-2020)
Table 15. Global Dolutegravir Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Dolutegravir Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Dolutegravir Sales Share by Manufacturers (2015-2020)
Table 18. Global Dolutegravir Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Dolutegravir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dolutegravir as of 2019)
Table 20. Dolutegravir Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Dolutegravir Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Dolutegravir Price (2015-2020) (USD/Pcs)
Table 23. Dolutegravir Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Dolutegravir Product Type
Table 25. Date of International Manufacturers Enter into Dolutegravir Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 28. Global Dolutegravir Sales Share by Type (2015-2020)
Table 29. Global Dolutegravir Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Dolutegravir Revenue Share by Type (2015-2020)
Table 31. Dolutegravir Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 33. Global Dolutegravir Sales Share by Application (2015-2020)
Table 34. North America Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 35. North America Dolutegravir Sales Market Share by Country (2015-2020)
Table 36. North America Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Dolutegravir Revenue Market Share by Country (2015-2020)
Table 38. North America Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 39. North America Dolutegravir Sales Market Share by Type (2015-2020)
Table 40. North America Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 41. North America Dolutegravir Sales Market Share by Application (2015-2020)
Table 42. Europe Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Dolutegravir Sales Market Share by Country (2015-2020)
Table 44. Europe Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Dolutegravir Revenue Market Share by Country (2015-2020)
Table 46. Europe Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Dolutegravir Sales Market Share by Type (2015-2020)
Table 48. Europe Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Dolutegravir Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Dolutegravir Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Dolutegravir Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Dolutegravir Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Dolutegravir Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Dolutegravir Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Dolutegravir Sales Market Share by Application (2015-2020)
Table 58. Latin America Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Dolutegravir Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Dolutegravir Revenue Market Share by Country (2015-2020)
Table 62. Latin America Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Dolutegravir Sales Market Share by Type (2015-2020)
Table 64. Latin America Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Dolutegravir Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Dolutegravir Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Dolutegravir Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Dolutegravir Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Dolutegravir Sales Market Share by Application (2015-2020)
Table 74. ViiV Healthcare (GSK) Corporation Information
Table 75. ViiV Healthcare (GSK) Description and Major Businesses
Table 76. ViiV Healthcare (GSK) Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. ViiV Healthcare (GSK) Product
Table 78. ViiV Healthcare (GSK) Recent Development
Table 79. Shanghai Desano Pharmaceuticals Corporation Information
Table 80. Shanghai Desano Pharmaceuticals Description and Major Businesses
Table 81. Shanghai Desano Pharmaceuticals Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Shanghai Desano Pharmaceuticals Product
Table 83. Shanghai Desano Pharmaceuticals Recent Development
Table 84. Mylan Corporation Information
Table 85. Mylan Description and Major Businesses
Table 86. Mylan Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Mylan Product
Table 88. Mylan Recent Development
Table 89. Aurobindo Pharma Corporation Information
Table 90. Aurobindo Pharma Description and Major Businesses
Table 91. Aurobindo Pharma Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Aurobindo Pharma Product
Table 93. Aurobindo Pharma Recent Development
Table 94. LAURUS Labs Corporation Information
Table 95. LAURUS Labs Description and Major Businesses
Table 96. LAURUS Labs Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. LAURUS Labs Product
Table 98. LAURUS Labs Recent Development
Table 99. Adcock Ingram Limited Corporation Information
Table 100. Adcock Ingram Limited Description and Major Businesses
Table 101. Adcock Ingram Limited Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Adcock Ingram Limited Product
Table 103. Adcock Ingram Limited Recent Development
Table 104. Global Dolutegravir Sales Forecast by Regions (2021-2026) (K Pcs)
Table 105. Global Dolutegravir Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Dolutegravir Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Dolutegravir Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. North America: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Europe: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Dolutegravir Sales Forecast by Region (2021-2026) (K Pcs)
Table 113. Asia Pacific: Dolutegravir Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Latin America: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Middle East and Africa: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Dolutegravir Players
Table 122. Dolutegravir Customers List
Table 123. Dolutegravir Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Dolutegravir Market Segments
Table 2. Ranking of Global Top Dolutegravir Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dolutegravir Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 10mg Tablets
Table 5. Major Manufacturers of 50mg Tablets
Table 6. COVID-19 Impact Global Market: (Four Dolutegravir Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Dolutegravir Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Dolutegravir Players to Combat Covid-19 Impact
Table 11. Global Dolutegravir Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Dolutegravir Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Dolutegravir Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Dolutegravir Sales Market Share by Regions (2015-2020)
Table 15. Global Dolutegravir Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Dolutegravir Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Dolutegravir Sales Share by Manufacturers (2015-2020)
Table 18. Global Dolutegravir Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Dolutegravir by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dolutegravir as of 2019)
Table 20. Dolutegravir Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Dolutegravir Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Dolutegravir Price (2015-2020) (USD/Pcs)
Table 23. Dolutegravir Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Dolutegravir Product Type
Table 25. Date of International Manufacturers Enter into Dolutegravir Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 28. Global Dolutegravir Sales Share by Type (2015-2020)
Table 29. Global Dolutegravir Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Dolutegravir Revenue Share by Type (2015-2020)
Table 31. Dolutegravir Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 33. Global Dolutegravir Sales Share by Application (2015-2020)
Table 34. North America Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 35. North America Dolutegravir Sales Market Share by Country (2015-2020)
Table 36. North America Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Dolutegravir Revenue Market Share by Country (2015-2020)
Table 38. North America Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 39. North America Dolutegravir Sales Market Share by Type (2015-2020)
Table 40. North America Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 41. North America Dolutegravir Sales Market Share by Application (2015-2020)
Table 42. Europe Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Dolutegravir Sales Market Share by Country (2015-2020)
Table 44. Europe Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Dolutegravir Revenue Market Share by Country (2015-2020)
Table 46. Europe Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Dolutegravir Sales Market Share by Type (2015-2020)
Table 48. Europe Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Dolutegravir Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Dolutegravir Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Dolutegravir Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Dolutegravir Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Dolutegravir Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Dolutegravir Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Dolutegravir Sales Market Share by Application (2015-2020)
Table 58. Latin America Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Dolutegravir Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Dolutegravir Revenue Market Share by Country (2015-2020)
Table 62. Latin America Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Dolutegravir Sales Market Share by Type (2015-2020)
Table 64. Latin America Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Dolutegravir Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Dolutegravir Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Dolutegravir Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Dolutegravir Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Dolutegravir Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Dolutegravir Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Dolutegravir Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Dolutegravir Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Dolutegravir Sales Market Share by Application (2015-2020)
Table 74. ViiV Healthcare (GSK) Corporation Information
Table 75. ViiV Healthcare (GSK) Description and Major Businesses
Table 76. ViiV Healthcare (GSK) Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. ViiV Healthcare (GSK) Product
Table 78. ViiV Healthcare (GSK) Recent Development
Table 79. Shanghai Desano Pharmaceuticals Corporation Information
Table 80. Shanghai Desano Pharmaceuticals Description and Major Businesses
Table 81. Shanghai Desano Pharmaceuticals Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Shanghai Desano Pharmaceuticals Product
Table 83. Shanghai Desano Pharmaceuticals Recent Development
Table 84. Mylan Corporation Information
Table 85. Mylan Description and Major Businesses
Table 86. Mylan Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Mylan Product
Table 88. Mylan Recent Development
Table 89. Aurobindo Pharma Corporation Information
Table 90. Aurobindo Pharma Description and Major Businesses
Table 91. Aurobindo Pharma Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Aurobindo Pharma Product
Table 93. Aurobindo Pharma Recent Development
Table 94. LAURUS Labs Corporation Information
Table 95. LAURUS Labs Description and Major Businesses
Table 96. LAURUS Labs Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. LAURUS Labs Product
Table 98. LAURUS Labs Recent Development
Table 99. Adcock Ingram Limited Corporation Information
Table 100. Adcock Ingram Limited Description and Major Businesses
Table 101. Adcock Ingram Limited Dolutegravir Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Adcock Ingram Limited Product
Table 103. Adcock Ingram Limited Recent Development
Table 104. Global Dolutegravir Sales Forecast by Regions (2021-2026) (K Pcs)
Table 105. Global Dolutegravir Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Dolutegravir Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Dolutegravir Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. North America: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. Europe: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Dolutegravir Sales Forecast by Region (2021-2026) (K Pcs)
Table 113. Asia Pacific: Dolutegravir Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Latin America: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Dolutegravir Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Middle East and Africa: Dolutegravir Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Dolutegravir Players
Table 122. Dolutegravir Customers List
Table 123. Dolutegravir Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Dolutegravir Product Picture
Figure 2. Global Dolutegravir Sales Market Share by Type in 2020 & 2026
Figure 3. 10mg Tablets Product Picture
Figure 4. 50mg Tablets Product Picture
Figure 5. Global Dolutegravir Sales Market Share by Application in 2020 & 2026
Figure 6. Prevent HIV Infection Following Potential Exposure
Figure 7. Other
Figure 8. Dolutegravir Report Years Considered
Figure 9. Global Dolutegravir Market Size 2015-2026 (US$ Million)
Figure 10. Global Dolutegravir Sales 2015-2026 (K Pcs)
Figure 11. Global Dolutegravir Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Dolutegravir Sales Market Share by Region (2015-2020)
Figure 13. Global Dolutegravir Sales Market Share by Region in 2019
Figure 14. Global Dolutegravir Revenue Market Share by Region (2015-2020)
Figure 15. Global Dolutegravir Revenue Market Share by Region in 2019
Figure 16. Global Dolutegravir Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Dolutegravir Revenue in 2019
Figure 18. Dolutegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Dolutegravir Sales Market Share by Type (2015-2020)
Figure 20. Global Dolutegravir Sales Market Share by Type in 2019
Figure 21. Global Dolutegravir Revenue Market Share by Type (2015-2020)
Figure 22. Global Dolutegravir Revenue Market Share by Type in 2019
Figure 23. Global Dolutegravir Market Share by Price Range (2015-2020)
Figure 24. Global Dolutegravir Sales Market Share by Application (2015-2020)
Figure 25. Global Dolutegravir Sales Market Share by Application in 2019
Figure 26. Global Dolutegravir Revenue Market Share by Application (2015-2020)
Figure 27. Global Dolutegravir Revenue Market Share by Application in 2019
Figure 28. North America Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 29. North America Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Dolutegravir Sales Market Share by Country in 2019
Figure 31. North America Dolutegravir Revenue Market Share by Country in 2019
Figure 32. U.S. Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. U.S. Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. Canada Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Dolutegravir Market Share by Type in 2019
Figure 37. North America Dolutegravir Market Share by Application in 2019
Figure 38. Europe Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 39. Europe Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Dolutegravir Sales Market Share by Country in 2019
Figure 41. Europe Dolutegravir Revenue Market Share by Country in 2019
Figure 42. Germany Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Germany Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. France Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.K. Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Italy Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Russia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Dolutegravir Market Share by Type in 2019
Figure 53. Europe Dolutegravir Market Share by Application in 2019
Figure 54. Asia Pacific Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 55. Asia Pacific Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Dolutegravir Sales Market Share by Region in 2019
Figure 57. Asia Pacific Dolutegravir Revenue Market Share by Region in 2019
Figure 58. China Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. China Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Japan Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. South Korea Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. India Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Australia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Taiwan Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Indonesia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Thailand Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Malaysia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Philippines Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Vietnam Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Dolutegravir Market Share by Type in 2019
Figure 81. Asia Pacific Dolutegravir Market Share by Application in 2019
Figure 82. Latin America Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 83. Latin America Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Dolutegravir Sales Market Share by Country in 2019
Figure 85. Latin America Dolutegravir Revenue Market Share by Country in 2019
Figure 86. Mexico Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Mexico Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Brazil Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Argentina Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Dolutegravir Market Share by Type in 2019
Figure 93. Latin America Dolutegravir Market Share by Application in 2019
Figure 94. Middle East and Africa Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 95. Middle East and Africa Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Dolutegravir Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Dolutegravir Revenue Market Share by Country in 2019
Figure 98. Turkey Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Turkey Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Saudi Arabia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. U.A.E Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Dolutegravir Market Share by Type in 2019
Figure 105. Middle East and Africa Dolutegravir Market Share by Application in 2019
Figure 106. ViiV Healthcare (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Shanghai Desano Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. LAURUS Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Adcock Ingram Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. North America Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
Figure 1. Dolutegravir Product Picture
Figure 2. Global Dolutegravir Sales Market Share by Type in 2020 & 2026
Figure 3. 10mg Tablets Product Picture
Figure 4. 50mg Tablets Product Picture
Figure 5. Global Dolutegravir Sales Market Share by Application in 2020 & 2026
Figure 6. Prevent HIV Infection Following Potential Exposure
Figure 7. Other
Figure 8. Dolutegravir Report Years Considered
Figure 9. Global Dolutegravir Market Size 2015-2026 (US$ Million)
Figure 10. Global Dolutegravir Sales 2015-2026 (K Pcs)
Figure 11. Global Dolutegravir Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Dolutegravir Sales Market Share by Region (2015-2020)
Figure 13. Global Dolutegravir Sales Market Share by Region in 2019
Figure 14. Global Dolutegravir Revenue Market Share by Region (2015-2020)
Figure 15. Global Dolutegravir Revenue Market Share by Region in 2019
Figure 16. Global Dolutegravir Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Dolutegravir Revenue in 2019
Figure 18. Dolutegravir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Dolutegravir Sales Market Share by Type (2015-2020)
Figure 20. Global Dolutegravir Sales Market Share by Type in 2019
Figure 21. Global Dolutegravir Revenue Market Share by Type (2015-2020)
Figure 22. Global Dolutegravir Revenue Market Share by Type in 2019
Figure 23. Global Dolutegravir Market Share by Price Range (2015-2020)
Figure 24. Global Dolutegravir Sales Market Share by Application (2015-2020)
Figure 25. Global Dolutegravir Sales Market Share by Application in 2019
Figure 26. Global Dolutegravir Revenue Market Share by Application (2015-2020)
Figure 27. Global Dolutegravir Revenue Market Share by Application in 2019
Figure 28. North America Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 29. North America Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Dolutegravir Sales Market Share by Country in 2019
Figure 31. North America Dolutegravir Revenue Market Share by Country in 2019
Figure 32. U.S. Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. U.S. Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. Canada Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Dolutegravir Market Share by Type in 2019
Figure 37. North America Dolutegravir Market Share by Application in 2019
Figure 38. Europe Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 39. Europe Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Dolutegravir Sales Market Share by Country in 2019
Figure 41. Europe Dolutegravir Revenue Market Share by Country in 2019
Figure 42. Germany Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Germany Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. France Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.K. Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Italy Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Russia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Dolutegravir Market Share by Type in 2019
Figure 53. Europe Dolutegravir Market Share by Application in 2019
Figure 54. Asia Pacific Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 55. Asia Pacific Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Dolutegravir Sales Market Share by Region in 2019
Figure 57. Asia Pacific Dolutegravir Revenue Market Share by Region in 2019
Figure 58. China Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. China Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Japan Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. South Korea Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. India Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Australia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Taiwan Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Indonesia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Thailand Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Malaysia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Philippines Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Vietnam Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Dolutegravir Market Share by Type in 2019
Figure 81. Asia Pacific Dolutegravir Market Share by Application in 2019
Figure 82. Latin America Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 83. Latin America Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Dolutegravir Sales Market Share by Country in 2019
Figure 85. Latin America Dolutegravir Revenue Market Share by Country in 2019
Figure 86. Mexico Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Mexico Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Brazil Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Argentina Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Dolutegravir Market Share by Type in 2019
Figure 93. Latin America Dolutegravir Market Share by Application in 2019
Figure 94. Middle East and Africa Dolutegravir Sales Growth Rate 2015-2020 (K Pcs)
Figure 95. Middle East and Africa Dolutegravir Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Dolutegravir Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Dolutegravir Revenue Market Share by Country in 2019
Figure 98. Turkey Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Turkey Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Saudi Arabia Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Dolutegravir Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. U.A.E Dolutegravir Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Dolutegravir Market Share by Type in 2019
Figure 105. Middle East and Africa Dolutegravir Market Share by Application in 2019
Figure 106. ViiV Healthcare (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Shanghai Desano Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. LAURUS Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Adcock Ingram Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. North America Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Dolutegravir Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Dolutegravir Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
